Basic Information
Basic information for AC022034.3-215-33aa
Peptide Name AC022034.3-215-33aa
Genome Position chr8:53394641-53394739[-]
Species Human
Peptide Sequence MKGHIQGATPGGLSFAFVPANAGQRSWKLGPTG
Peptide Length 33
Unique No (AC022034.3-219-33aa-2,AC022034.3-212-33aa-2,AC022034.3-202-33aa-1,AC022034.3-222-33aa-1,AC022034.3-204-33aa-2,AC022034.3-217-33aa-2,AC022034.3-210-33aa-1,AC022034.3-211-33aa-2,AC022034.3-214-33aa-2,AC022034.3-205-33aa-1,AC022034.3-201-33aa-1,AC022034.3-218-33aa-1)
Grand Average of Hydropathicity -0.197
Relative Molecular Mass 3916.37
Experimental Evidences no
lncRNA ID/Name ENSG00000253369;AC022034.3
Transcript ID/Name ENST00000665810;AC022034.3-215
Transcript Length 1900
Coding Ability 0.5105
DNA Sequence Corresponding to Peptide ATGAAGGGCCACATCCAAGGAGCTACCCCAGGAGGCCTCTCATTTGCATTTGTCCCCGCTAATGCAGGACAGAGATCATGGAAGTTGGGCCCGACTGGA
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :